Ethical Oncology Science's Series A - II Round

Ethical Oncology Science raised a round of funding on July 30, 2009. Investors include Aescap Venture.

Ethical Oncology Science (EOS) is a biopharmaceutical company committed to the development of novel medicines for the treatment of cancer. EOS is seeking to build a second portfolio of molecular targe…

Articles about Ethical Oncology Science's Series A - II Round: